Literature DB >> 15935313

MR imaging of the gallbladder and biliary system.

Samantha L Heller1, Vivian S Lee.   

Abstract

MR imaging is an established technique for the diagnosis of a spectrum of biliary and gallbladder pathologies and continues to improve with the advent of technologic advances, including new contrast agents and new sequences that are capable of improving upon the contrast resolution and signal-to-noise that are afforded by conventional MR imaging. These improvements already have shown promise for the increasing role of MRC as the initial modality in assessing living liver donors and evaluating post-operative hepato-biliary complications. Improved spatial resolution and the added functional or physiologic information afforded by MR imaging promise ever expanding clinical applicability and usefulness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935313     DOI: 10.1016/j.mric.2005.03.003

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  5 in total

Review 1.  Pancreatic and biliary anomalies: imaging in 2008.

Authors:  Sudha A Anupindi
Journal:  Pediatr Radiol       Date:  2008-05

2.  3-T MRI of the biliary tract variations.

Authors:  Hakan Onder; Muhammed Sıddık Ozdemir; Güven Tekbaş; Faysal Ekici; Hatice Gümüş; Aslan Bilici
Journal:  Surg Radiol Anat       Date:  2012-09-13       Impact factor: 1.246

3.  The effective use of acai juice, blueberry juice and pineapple juice as negative contrast agents for magnetic resonance cholangiopancreatography in children.

Authors:  Mark E Bittman; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2014-02-27

4.  The efficacy of pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography.

Authors:  Sheryl Mohabir; Richard D Pitcher; Rubeshan Perumal; Matthew D M Goodier
Journal:  SA J Radiol       Date:  2020-07-29

Review 5.  Biliary tract neoplasms: diagnosis and staging.

Authors:  Richard M Gore; Ryan P Shelhamer
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.